
To preliminary evaluate the clinical effects of probiotics in individuals with symptomatic oral lichen planus and the possible mechanisms of action. The probiotic VSL#3 was safe and well tolerated. The present proof‐of‐concept study provides some weak, not convincing indication of the biological and clinical effects of probiotic VSL#3 in individuals with painful oral lichen planus.
Like
Save
Share